Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Simulation studies and the alignment of interests.

Godefridus G van Merode1, Siebren Groothuis, Milou Schoenmakers

  • 1Department of Health Organization, Policy and Economics, Maastricht University, The Netherlands. F.vanMerode@ beoz.unimaas.nl

Health Care Management Science
|May 8, 2002
PubMed
Summary

This study presents a simulation model to optimize chemotherapy drug inventory, balancing drug availability, patient needs, and costs. It analyzes real-world deviations from model recommendations and proposes solutions for improved patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intraoperative fluorescence-guided fresh frozen sectioning for margin control in head and neck cancer: phase 2 clinical trial.

Nature communications·2026
Same author

Extemporaneous Compounding, Pharmacy Preparations and Related Product Care in the Netherlands.

Pharmaceutics·2025
Same author

Towards medical imaging of drug photoactivation: Development of light responsive magnetic resonance imaging and chemical exchange saturation transfer contrast agents.

Smart molecules : open access·2025
Same author

Heterogeneity of CD8 T-Cell Changes in Advanced Melanomas After Initiation of Immunotherapy.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Measurement of cyclosporin induced changes in P-glycoprotein function at the human blood-brain barrier using [<sup>18</sup>F]MC225 and PET.

European journal of nuclear medicine and molecular imaging·2025
Same author

Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine.

NPJ vaccines·2024

Area of Science:

  • Oncology
  • Health Services Research
  • Operations Research

Background:

  • Chemotherapy relies on cytostatic drugs with limited shelf lives.
  • Production and inventory management of these drugs face challenges due to spoilage and unpredictable patient readiness.
  • Current practices may lead to suboptimal patient outcomes and increased healthcare costs.

Purpose of the Study:

  • To develop and present a simulation model for optimizing cytostatic drug inventory.
  • To analyze the impact of drug type and patient type on waiting times and costs.
  • To investigate discrepancies between simulation model recommendations and actual practice, and propose solutions.

Main Methods:

  • Development of a simulation model to evaluate different inventory and production strategies for cytostatic drugs.

Related Experiment Videos

  • Analysis of key performance indicators including patient waiting times and associated costs.
  • Qualitative analysis of actor behavior in clinical practice compared to model-driven recommendations.

    • Main Results:

    • The simulation model quantifies the trade-offs between drug availability, spoilage, waiting times, and costs for various cytostatic drug and patient combinations.
    • Identified specific reasons for non-adherence to simulation-based recommendations in real-world healthcare settings.
    • Proposed actionable solutions to bridge the gap between theoretical optimization and practical implementation.

    Conclusions:

    • Simulation modeling provides a valuable tool for optimizing chemotherapy drug logistics.
    • Addressing practical challenges and actor behavior is crucial for effective implementation of optimized strategies.
    • Improved inventory management can enhance patient care and reduce healthcare expenditures in chemotherapy services.